Original Research
Published on 12 Feb 2026
Decoding the role of RPL38 in lung adenocarcinoma: a multi-omics approach
Frontiers in Immunology
doi 10.3389/fimmu.2026.1778481
- 308 views
49,797 Publications
volumes
Volume 17 - 2026
Original Research
Published on 12 Feb 2026
Targeted expression of the immunomodulatory peptide Scy by engineered Escherichia coli Nissle 1917 for alleviating enterotoxigenic E. coli infection
Frontiers in Immunology
doi 10.3389/fimmu.2026.1698243
- 498 views
Mini Review
Published on 12 Feb 2026
Clinically oriented immune heterogeneity in prostate cancer: emerging targets and strategies
Frontiers in Immunology
doi 10.3389/fimmu.2026.1753718
- 346 views
Original Research
Published on 12 Feb 2026
Efficacy of Interleukin 8 (IL-8) in the detection of urinary tract infection
Frontiers in Immunology
doi 10.3389/fimmu.2026.1684579
- 345 views
Original Research
Published on 12 Feb 2026
Tissue-invasive CMV disease is associated with poor prognosis during remission induction therapy for autoimmune inflammatory rheumatic diseases
Frontiers in Immunology
doi 10.3389/fimmu.2026.1696516
- 429 views
Review
Published on 12 Feb 2026
Beyond inflammation: metabolic implications of biological and TsDMARD therapies in dermatologic and rheumatologic diseases
Frontiers in Immunology
doi 10.3389/fimmu.2026.1668159
- 541 views
Original Research
Published on 12 Feb 2026
NCF2 facilitates M2 macrophage polarization in glioblastoma through activation of the notch1–osteopontin axis
Frontiers in Immunology
doi 10.3389/fimmu.2026.1743950
- 405 views
Correction
Published on 12 Feb 2026
Correction: Editorial: Unveiling the next generation of cancer immunity & immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2026.1784505
- 206 views
Case Report
Published on 12 Feb 2026
Temporal association of diffuse large B-cell lymphoma with PD-1 inhibitor therapy in a patient with gastric adenocarcinoma: a case report
Frontiers in Immunology
doi 10.3389/fimmu.2026.1763711
- 419 views
Mini Review
Published on 12 Feb 2026
Tumor immune-vascular crosstalk: synergy and translation of immune checkpoint inhibitors and anti-angiogenic agents in melanoma
Frontiers in Immunology
doi 10.3389/fimmu.2026.1760044
- 407 views
Original Research
Published on 12 Feb 2026
Characterization and diversity of defense systems in Providencia pathogen
Frontiers in Immunology
doi 10.3389/fimmu.2026.1755933
- 293 views
Editorial
Published on 12 Feb 2026
Editorial: Exploring sulfur compounds’ role in inflammation and therapeutic potential
Frontiers in Immunology
doi 10.3389/fimmu.2026.1804564
- 232 views
Editorial
Published on 12 Feb 2026
Editorial: Mechanisms and therapeutic opportunities of T-cell impairment in cancer immunity and immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2026.1795868
- 452 views
Original Research
Published on 12 Feb 2026
BDCA2 plays a central role in the binding, internalization and response of plasmacytoid dendritic cells to vidutolimod
Frontiers in Immunology
doi 10.3389/fimmu.2026.1769287
- 305 views
Correction
Published on 12 Feb 2026
Correction: Multiplexed longitudinal analysis of the cellular and microbial dynamics of acute polymicrobial sepsis in mice
Frontiers in Immunology
doi 10.3389/fimmu.2026.1794085
- 141 views
Case Report
Published on 12 Feb 2026
Case Report: Targeted interleukin-6 blockade by siltuximab for cytokine release syndrome control and infection limitation in thirteen patients treated with bi-specific T-cell engagers
Frontiers in Immunology
doi 10.3389/fimmu.2026.1749348
- 335 views
Original Research
Published on 12 Feb 2026
Identification and validation of prognostic genes related to glycolysis and M2 macrophage in hepatocellular carcinoma: an integrated analysis of bulk RNA sequencing and single-cell RNA sequencing
Frontiers in Immunology
doi 10.3389/fimmu.2026.1710411
- 468 views
Review
Published on 12 Feb 2026
The emerging role of m6A methylation in prostate-related diseases: mechanisms and clinical implications
Frontiers in Immunology
doi 10.3389/fimmu.2026.1685015
- 229 views
Editorial
Published on 12 Feb 2026
Editorial: Antibody-mediated thrombotic disease
Frontiers in Immunology
doi 10.3389/fimmu.2026.1800389
- 181 views
Mini Review
Published on 12 Feb 2026
Beyond the Th2 paradigm: CD4+ cytotoxic T lymphocytes as key drivers of tissue damage and fibrosis in IgG4-related disease
Frontiers in Immunology
doi 10.3389/fimmu.2026.1781462
- 279 views
Original Research
Published on 12 Feb 2026
Baseline glucose-to-lymphocyte ratio predicts nivolumab outcomes in advanced non-small cell lung cancer: a multicenter retrospective study
Frontiers in Immunology
doi 10.3389/fimmu.2026.1714533
- 383 views
Original Research
Published on 12 Feb 2026
Nocardia rubra cell wall skeleton-induced MARCO expression: implications for improved phagocytosis and cytokine secretion in tumor-associated macrophages
Frontiers in Immunology
doi 10.3389/fimmu.2026.1611476
- 333 views
Original Research
Published on 12 Feb 2026
Cross-talk between lipopolysaccharide tolerance and AGEs in the regulation of macrophage inflammation and cholesterol efflux
Frontiers in Immunology
doi 10.3389/fimmu.2026.1669028
- 267 views